You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
13 July 2022
Resaphene Suisse AG: FDA approval process for tinnitus therapy tinniwell continues (news with additional features)
18 May 2020
Resaphene Suisse AG: Tinnitus: 4 phases until healing in the Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell
31 March 2020
Resaphene Suisse AG: Correction of the ad hoc announcement dated March 30, 2020 Resaphene Suisse AG has announced the withdrawal of inclusion in the Vienna MTF at the Vienna Stock Exchange
30 March 2020
Resaphene Suisse AG: Resaphene Suisse AG has applied for delisting at the Vienna Stock Exchange
21 January 2020
Resaphene Suisse AG: Charité Ethics Committee in Berlin approves study on tinniwell tinnitus therapy
4 September 2019
Resaphene Suisse AG: Erfolgreicher Einsatz von Wärmetherapie bei Schlafstörungen in der Tinnitus-Therapie (News mit Zusatzmaterial)
5 June 2019
Resaphene Suisse AG: US Patent Office Announces Patent for Tinnitus Therapy tinniwell (news with additional features)
17 March 2019
Resaphene Suisse AG: Tinnitus-Therapie tinniwell wird von Krankenkassen übernommen (News mit Zusatzmaterial)
24 January 2019
DGAP-DD: Resaphene Suisse AG english
23 January 2019
20 December 2018
7 December 2018
Resaphene Suisse AG: European Patent Office announces patent for tinnitus therapy (news with additional features)
2 October 2018
30 September 2018
Resaphene Suisse AG: Annual General Meeting approves capital increase with subscription rights for existing shareholders
27 September 2018
13 August 2018
Resaphene Suisse AG: Breakthrough in tinnitus therapy (news with additional features)
26 July 2018
16 July 2018
3 July 2018
21 June 2018
Resaphene Suisse AG: Die Resaphene Suisse AG startet an der Wiener Börse
